This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In Reply.—With regard to Fisher's letter, we agree that outpatient therapy with intravenously administered immunoglobulin is both feasible and less costly than in-hospital treatment for human immunodeficiency virus—associated thrombocytopenia. Indeed, since publication of our article, we have treated some outpatients with intravenously administered immunoglobulin in a dose of 50 g given over a six-hour period as a single infusion, repeating this dose as clinically indicated.
GREEN D. Intravenous Immunoglobulin Therapy in Human Immunodeficiency Virus—Associated Thrombocytopenia-Reply. Arch Intern Med. 1989;149(2):467. doi:10.1001/archinte.1989.00390020151037
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.